Graphical User Interface
    84.
    发明申请
    Graphical User Interface 有权
    图形用户界面

    公开(公告)号:US20150122830A1

    公开(公告)日:2015-05-07

    申请号:US14591954

    申请日:2015-01-08

    IPC分类号: A61J7/04

    摘要: In order to monitor the administration of medicament portions Ta in a reliable and simple manner, the invention provides a display device for a dispenser for medicament portions Ta, it being necessary to administer the medicament portions at regularly recurring reference administration times, and the display device comprising a display 1 and an electronic actuation means for the display, characterized in that the display comprises a first visualization means 30, 40 for displaying a first period of time between a first reference administration time and the current time, and the first reference administration time being distinguished in that the medicament portion has not been taken by the first reference administration time.

    摘要翻译: 为了以可靠和简单的方式监视药物部分Ta的给药,本发明提供了用于药物部分Ta的分配器的显示装置,需要以规律地重复的参考给药时间来施用药物部分,并且显示装置 包括显示器1和用于显示器的电子致动装置,其特征在于,显示器包括用于显示第一参考管理时间和当前时间之间的第一时间段的第一可视化装置30,40和第一参考管理时间 区别在于第一参考给药时间没有服用药物部分。

    SUBSTITUTED IMIDAZOPYRIDAZINES
    87.
    发明申请
    SUBSTITUTED IMIDAZOPYRIDAZINES 有权
    取代的咪唑吡啶

    公开(公告)号:US20150104526A1

    公开(公告)日:2015-04-16

    申请号:US14384828

    申请日:2013-03-11

    摘要: The present invention relates to substituted imidazopyridazine compounds of general formula I in which R3, R5 and A are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.

    摘要翻译: 本发明涉及通式I的取代的咪唑并哒嗪化合物,其中R3,R5和A如权利要求中所定义,所述化合物的制备方法,药物组合物和包含所述化合物的组合以及所述化合物用于制造 用于治疗或预防疾病,特别是高增殖性和/或血管生成障碍的药物组合物,作为唯一试剂或与其它活性成分组合。